MetaCap

Alamar Biosciences Inc. (ALMR)

NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

26.48-2.20 (-7.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ALMR stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.13
52-week range
18.85 – 39.61
Day range
26.24 – 28.22
Volume / Avg
712.58K / 628.70K
Beta
—

52-week range

$18.85$39.61

ALMR stock today

Shares of Alamar Biosciences (ALMR) finished lower on Nov 20 at $26.48, a drop of 7.67% or $2.20 per share, versus the S&P 500's 3.70% decline. At this level, ALMR sits in the middle of its 52-week range of $18.85 to $39.61: 33.1% below the high, set on Oct 6, 2026 and 40.5% above the low. Alamar Biosciences has posted a net loss over the last twelve months (EPS of -$1.13), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Alamar Biosciences

Company profile

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics.

Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Dr. Yuling Luo Ph.D.
Headquarters
Fremont, CA
Employees
308
IPO year
2026

Analyst forecast

Forecast

Consensus (5 analysts)

buy

Avg. price target

$37.00+39.73%

  • Strong buy 1
  • Buy 3
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $34.00High $45.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$-0.19 vs $-0.22
Surprise
+13.64%

ALMR news

All ALMR news

Alamar Biosciences peers

Industrials sector
ALMR peer companies
CompanyPrice% ChgMarket capCompare
CTKBCytek Biosciences Inc.6.12-3.16%$800.40Mvs ALMR
PACBPacific Biosciences of California Inc.1.63-7.39%$508.95Mvs ALMR
NAUTNautilus Biotechnology Inc.2.12-2.30%$270.03Mvs ALMR
LABStandard BioTools Inc.0.631+2.82%$249.11Mvs ALMR
QTRXQuanterix Corporation1.96-3.45%$93.06Mvs ALMR
SEERSeer Inc. Class A1.36-1.81%$75.91Mvs ALMR
HBIOHarvard Bioscience Inc.8.66-0.23%$39.60Mvs ALMR
RPIDRapid Micro Biosystems Inc. Class A0.735-0.04%$37.37Mvs ALMR

Indexes, lists and sector

Alamar Biosciences stock FAQ

What is Alamar Biosciences's stock price today?

ALMR last traded at $26.48 as of Nov 20, 4:00 PM EST, down 7.67% on the day. Prices are delayed at least 15 minutes.

Who is Alamar Biosciences's CEO?

Dr. Yuling Luo Ph.D. is the chief executive officer of Alamar Biosciences Inc., which has about 308 employees.

What is the ALMR 52-week high?

The 52-week high for ALMR is $39.61 and the 52-week low is $18.85. The stock is currently 33.1% below its high.

Compare ALMR